Read more about the latest developments in MS research, treatments and specialist care, plus the latest updates on our work and the efforts of our amazing supporters
The MS Trust sends out a weekly news alert which includes the latest updates from the MS Trust, latest news, blogs and a news feed from MS in the Media.
Read our latest news
- Stem cells effective in aggressively relapsing MS
- Benefits of early DMD treatment
- Guidelines for MS treatment during pregnancy published
- Mindfulness helps mood and fatigue
People with relapsing remitting MS starting early treatment with a disease modifying drug have a lower risk of converting to secondary progressive MS, according to a study of medical records.
An international study for people with highly active relapsing multiple sclerosis has reported that those having stem cell treatment had slower disability progression.
- Cooling helps with exercise
- Rituximab and SPMS
- Ocrevus and arm function in PPMS
- Plasma cells from gut can turn off brain inflammation
New guidelines for pregnancy care in multiple sclerosis, drawn up by a panel of UK experts including the MS Trust, have been published.
- Relapses more likely in people with food allergies
- Reducing Ocrevus injection site reactions
- Fampridine and walking speed
Living with MS in the family does not only affect the person with MS, but their loved ones as well. In this guest blog, Jen who is a full time carer for her husband Dave, writes about their life living with advanced MS.
- SMC approves Ocrevus
- Australian stem cell study
- Switching interferons increases relapse risk
What causes MS? This is something we yet don't know, but there are a lot of theories out there. In this blog guest blogger Emily, takes us through some of them.
The Scottish Medicines Consortium (SMC) has approved Ocrevus (ocrelizumab) as an NHS treatment for relapsing remitting multiple sclerosis in Scotland.
When Katie Silverthorne was diagnosed with MS when she was just 23, she had no idea that her condition would one day spur her on to open her own successful business. In this blog, Katie writes about coming to terms with her MS diagnosis and how it gave her the courage to take a leap of faith and start her own business.
Is there a funny side to MS? We talk to stand-up comedian Will Berard who has MS, about life with the condition, getting diagnosed and raising awareness through comedy.
- Depression affected by lifestyle factors
- Gilenya approved for childhood MS
- Lemtrada warning issued
The European Commission has approved the extension of the licence for Gilenya (fingolimod) to include treatment of children and adolescents 10 years or older with relapsing remitting MS.
- Cognition affects ability to work
- Gender differences in diagnosis
- Rare Gilenya side effect warning
- Fampyra turned down in Scotland
Ben Dorward, lead neurosciences pharmacist at Sheffield Teaching Hospitals NHS Foundation Trust, describes his project - to jointly develop an IT system that links prescription management to blood monitoring and can be accessed by the MS and pharmacy teams.
For many, MS nurses are a lifeline but, sadly, we know that some people are missing out on the vital care and support they provide, simply because there are currently not enough of them. The MS Trust recently published a report into nurse provision across the UK, this blog looks at some of the key findings.
- Heavy caseloads for MS specialist nurses
- Ocrevus slows progression in upper limbs
- Parenting with MS
- Trains and planes and disability
- Vitamin D recommendation